The current pregnant women living with hiv antiretroviral therapy coverage for pmtct in Tunisia is 40%, which has increased by 9% (29.0%) since 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Tunisia
No matching regions
Data currently not available for this time and region, try a different time period
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Tunisia
PMTCT antiretroviral therapy coverage
More indicators for Tunisia
Tunisia PMTCT antiretroviral therapy coverage between 2000 and 2022
Period | PMTCT antiretroviral therapy coverage | Change |
---|---|---|
2022 | 40% | 9% |
2021 | 31% | 3% |
2020 | 28% | 10% |
2019 | 18% | 6% |
2018 | 12% | 1% |
2017 | 11% | 1% |
2016 | 12% | 5% |
2015 | 17% | 9% |
2014 | 26% | 14% |
2013 | 12% | 3% |
2012 | 9% | 1% |
2011 | 10% | 1% |
2010 | 9% | 6% |
2009 | 3% | 0% |
2008 | 3% | 1% |
2007 | 2% | 2% |
2006 | 0% | 0% |
2005 | 0% | 3% |
2004 | 3% | 3% |
2003 | 6% | 2% |
2002 | 4% | 4% |
2001 | 0% | 0% |
2000 | 0% |